Rothschild Investment »

Entrada Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-12-31 $21 2 10.50
2025-03-31 $181 20 9.05

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Microsoft Corp Stock (MSFT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Blackstone Stock (BX)
Invesco Rafi Us 1000 Etf Etf (PRF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Capital Group Dividend Growers Etf Etf (CGDG)
Johnson & Johnson Stock (JNJ)
Meta Platforms Inc Cl A Stock (META)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics